Parliamentary questions

743. Deputy David Cullinane asked the Minister for Health the reason there is no mechanism in place for funding access to cancer therapies which are available at the North West Cancer Centre in Altnagelvin but which are not yet reimbursed in this State (details supplied); and if she will make a statement on the matter. [52843/26]

744. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No.1011 of 16 June 2026, in which the HSE confirmed that full costing of the National Model of Care for Obesity is dependent on the forthcoming Obesity Policy and Action Plan (OPAP): the expected publication date for OPAP; whether a costed implementation plan will be developed and published before or only after…

745. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1091 of 19 May 2026, in which her Department confirmed that no HSE national guidance currently exists on appropriate intervals for repeat lipid profile testing, and that an advice note on lipid profile testing is planned by the Laboratory Services Reform Programme, the timeline for publication of this advic…

746. Deputy Malcolm Byrne asked the Minister for Health if there is a specific policy within her Department that seeks to preclude those elected to local authorities from any boards that she may appoint; the rationale behind any such policy; the way in which it aligns with encouraging participation in local government; and if she will make a statement on the matter. [52857/26]

747. Deputy Malcolm Byrne asked the Minister for Health to commit to preparing legislation to not automatically exclude members of local authorities from consideration for appointment to State boards; and to set out the reasons such persons would be excluded. [52875/26]

748. Deputy Claire Kerrane asked the Minister for Health the reason a drug (details supplied) is not accessible in Ireland to cancer patients despite approval by the European Medicines Agency and its accessibility in many other parts of the EU and in the North of Ireland, if she will examine this and make the drug available for cancer patients where their oncology team has recommended it; and if s…

749. Deputy Charles Ward asked the Minister for Health further to Parliamentary Question No. 2415 of 9 June 2026, the reason this data was not provided; when this data will be provided; and the most common reasons recorded for claim adjustment in each year from 2020 to date (details supplied) [52892/26]

750. Deputy Colm Burke asked the Minister for Health her views on extending publicly funded access to continuous glucose monitoring to all women with type 2 diabetes during pregnancy; and if she will make a statement on the matter. [52893/26]

751. Deputy Colm Burke asked the Minister for Health the number of people with a clinical diagnosis of type 1 diabetes who are currently ineligible for publicly funded continuous glucose monitoring access; and if she will make a statement on the matter. [52894/26]

752. Deputy Colm Burke asked the Minister for Health if she will consider widening access to continuous glucose monitoring (CGM) for women with type 2 diabetes during pregnancy (details supplied); and if she will make a statement on the matter. [52895/26]

753. Deputy Colm Burke asked the Minister for Health if the ongoing review of the preferred continuous glucose monitoring (CGM) sensors evaluation will encompass a consideration of ensuring that all patients with type one diabetes have access to CGM; and if she will make a statement on the matter. [52898/26]

754. Deputy Colm Burke asked the Minister for Health whether the ongoing review of the preferred continuous glucose monitoring (CGM) sensors evaluation will lead to a HTA of CGM sensors for patients with type 2 diabetes; and if she will make a statement on the matter. [52899/26]

755. Deputy Barry Heneghan asked the Minister for Health whether the reimbursement arrangements under the community drugs schemes will be reviewed to ensure that patients are not financially disadvantaged when unlicensed medicines must be supplied as a result of shortages of licensed products; and if she will make a statement on the matter. [52900/26]

756. Deputy Barry Heneghan asked the Minister for Health whether her Department has assessed the financial impact of medicine shortages on residents of private nursing homes supported under the fair deal scheme, particularly where unlicensed medicines attract additional costs that are not fully covered under existing reimbursement arrangements; and if she will make a statement on the matter. [5290…

757. Deputy Barry Heneghan asked the Minister for Health the measures that are being taken by her Department and the HSE to minimise the impact of shortages of essential medicines, including medicines used in the treatment of heart failure and cardiovascular disease, and to ensure continuity of treatment for patients; and if she will make a statement on the matter. [52902/26]

758. Deputy Barry Heneghan asked the Minister for Health whether guidance has been issued to the HSE and community pharmacies regarding the reimbursement of unlicensed medicines supplied in place of licensed medicines that are unavailable due to national shortages; and if she will make a statement on the matter. [52903/26]

759. Deputy Barry Heneghan asked the Minister for Health the number and name of medicines currently subject to national shortages for which pharmacies are routinely sourcing unlicensed alternatives, in tabular form; whether her Department has assessed the additional costs incurred by medical card patients as a consequence; and if she will make a statement on the matter. [52904/26]

760. Deputy Michael Cahill asked the Minister for Health to provide a list of locations where hospital sessions are available for special needs patients under general anaesthetic nationwide; the relevant waiting lists for each in each of the past four years; the number of patients treated in each unit under general anaesthetic in each of the past four years and to date in 2026; and if she will mak…

761. Deputy Michael Cahill asked the Minister for Health the waiting list numbers and waiting times for all specialist services in Dublin and Cork Dental Schools in each of the past four years and to date in 2026; and if she will make a statement on the matter. [52919/26]

762. Deputy Sorca Clarke asked the Minister for Health if she will provide details of any assessment undertaken by her Department on extending publicly funded access to the shingles vaccine for cancer patients and other immunocompromised individuals; whether such a proposal has been considered following recommendations from the National Immunisation Advisory Committee; and if she will make a state…

763. Deputy Sorca Clarke asked the Minister for Health the estimated annual cost of providing the shingles vaccine free-of-charge to cancer patients who are clinically advised to receive it; whether this option has been examined by her Department; and if she will publish any cost-benefit analysis undertaken. [52922/26]

764. Deputy Sorca Clarke asked the Minister for Health the number of cancer patients who have received financial assistance from the State towards the cost of the shingles vaccine in each of the past five years; and the supports currently available to patients who are advised by their consultant to receive the vaccine but cannot afford it. [52923/26]

765. Deputy Sorca Clarke asked the Minister for Health whether consideration has been given to including the shingles vaccine on the list of medicines and treatments available without charge to eligible cancer patients under publicly funded cancer care, where the vaccine is clinically indicated to reduce the risk of complications arising during treatment; and if she will make a statement on the ma…

766. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Questions Nos. 1085, 1086, 1089, 1092 and 1094 of 19 May 2026, which confirmed there is no separate governance structure overseeing laboratory utilisation nationally, whether her Department will now establish an interim national oversight mechanism pending full rollout of MedLIS and the Regional Laboratory Networks; and…

767. Deputy Ken O'Flynn asked the Minister for Health further to Parliamentary Question No. 1089 of 19 May 2026, which confirmed MedLIS duplicate detection is currently deployed only in Beaumont Hospital and Cavan General Hospital, the projected timeline and sequencing for national rollout of MedLIS to all other hospital sites; and if she will make a statement on the matter. [52936/26]